Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Canntab Therapeutics Ltd (CTABF)

Canntab Therapeutics Ltd (CTABF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CTABF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0020 unch
on 06/28/24
0.0087 -77.01%
on 05/29/24
-0.0053 (-72.60%)
since 03/13/24
3-Month
0.0020 unch
on 06/28/24
0.0087 -77.01%
on 05/29/24
+0.0004 (+25.00%)
since 03/11/24
52-Week
0.0016 +25.00%
on 03/11/24
0.0128 -84.38%
on 09/14/23
-0.0115 (-85.19%)
since 06/21/23

Most Recent Stories

More News
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order

Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the "Corporation") announces that the Ontario Securities Commission (the...

CTABF : 0.0020 (unch)
PILL.CN : 0.0050 (unch)
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0020 (unch)
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

PILL.CN : 0.0050 (unch)
CTABF : 0.0020 (unch)
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO

/CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN)(OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene...

CTABF : 0.0020 (unch)
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN)(OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...

CTABF : 0.0020 (unch)
Canntab Corporate Update

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

PILL.CN : 0.0050 (unch)
CTABF : 0.0020 (unch)
Canntab Corporate Update

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0020 (unch)
Canntab Engages Hamish Sutherland as Strategic Advisor

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0020 (unch)
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids

The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand...

OTC.VN : 0.325 (+12.07%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
CTABF : 0.0020 (unch)
Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...

CTABF : 0.0020 (unch)

Key Turning Points

3rd Resistance Point 0.0020
2nd Resistance Point 0.0020
1st Resistance Point 0.0020
Last Price 0.0020
1st Support Level 0.0020
2nd Support Level 0.0020
3rd Support Level 0.0020

See More

52-Week High 0.0128
Fibonacci 61.8% 0.0085
Fibonacci 50% 0.0072
Fibonacci 38.2% 0.0059
Last Price 0.0020
52-Week Low 0.0016

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar